Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. 2021

Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
Department of Surgery, Seoul National University Hospital, Seoul 03080, Korea.

Due to the lack of appropriate tumor markers with optimal cut-off values to predict the prognosis of gallbladder cancer (GBC), this study aimed to demonstrate the relationship between prognosis and the levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), and to determine optimal thresholds. In total, 539 patients diagnosed with GBC were examined. The relationship between tumor marker levels and overall survival (OS) was analyzed. The C-tree method was used to suggest tumor marker thresholds, and multivariate analysis was conducted to identify prognostic factors for overall survival. The mean age of the patients was 65.3 years, and the 5-year overall survival rate in all patients was 68.9%. Following the C-tree method, the optimal cut-off value was set at 5 IU/mL for CEA and at 65 IU/mL for CA 19-9. Multivariate analysis revealed that age, CA 19-9 level, operative method, T stage, and N stage were significant prognostic factors for OS. Consequently, CA 19-9 had a stronger association with prognosis than CEA, and 65 IU/mL for CA 19-9 may be suggestive in evaluating the prognosis of GBC. Moreover, it could be an effective indicator for determining the surgical extent necessary and the need for adjuvant treatment.

UI MeSH Term Description Entries

Related Publications

Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
January 1986, Bulletin du cancer,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
March 1991, Changgeng yi xue za zhi,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
October 1996, Journal of gastroenterology,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
June 2021, Asian journal of surgery,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
January 2019, Translational gastroenterology and hepatology,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
August 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
January 2001, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
November 1996, Annals of clinical biochemistry,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
November 2017, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Myongjin Kim, and Hongbeom Kim, and Youngmin Han, and Heeju Sohn, and Jae Seung Kang, and Wooil Kwon, and Jin-Young Jang
January 2001, Voprosy onkologii,
Copied contents to your clipboard!